冠心病是中年以上人们的常见病和多发病,是当今世界上死亡率最高的疾病之一。在我国占死亡疾病中的第一位。而血脂和胆固醇过高又是冠心病的主要致病因素。因此,国内外都在积极进行降血脂药物的研究,并取得了一定的成就。但因绝大部分降血脂药物都分别具有不同程度的副作用,它们的应用也就受到了限制。 Coronary heart disease is a common and frequently occurring disease in people over middle age and is one of the most deadly diseases in the world today. In our country accounted for the first death sickness. The high blood lipids and cholesterol is the main risk factor for coronary heart disease. Therefore, both at home and abroad are actively engaged in lipid-lowering drug research, and achieved some success. However, because most lipid-lowering drugs have different degrees of side effects, their application is limited.